Immunosuppressant-induced metabolic toxicities

This publication has 122 references indexed in Scilit:

• LOW-DOSE CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS WITH SUBOPTIMAL RENAL FUNCTION1,2
  Transplantation, 1998
• MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-ASSOCIATED NEPHROTOXICITY
  Transplantation, 1998
• METABOLIC FACTORS HAVE A MAJOR IMPACT ON KIDNEY ALLOGRAFT SURVIVAL
  Transplantation, 1997
• Management of the Cardiac Transplant Recipient: Roles of the Transplant Cardiologist and Primary Care Physician
  The American Journal of the Medical Sciences, 1997
• STEROID WITHDRAWAL IN MYCOPHENOLATE MOFETIL-TREATED RENAL ALLOGRAFT RECIPIENTS
  Transplantation, 1997
• THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE A, CYCLOSPORINE G, AND FK506 ON BONE MINERAL METABOLISM IN VIVO
  Transplantation, 1994
• Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats
  Calcified Tissue International, 1993
• EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTS
  Transplantation, 1991
• POSTTRANSPLANT HYPERGLYCEMIA
  Transplantation, 1989
• Bone loss in diabetes: Effects of metabolic state
  Diabetologia, 1979